Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Current and future treatments for Alzheimer's disease.

Yiannopoulou KG, Papageorgiou SG.

Ther Adv Neurol Disord. 2013 Jan;6(1):19-33. doi: 10.1177/1756285612461679.

2.

Disease-modifying treatments for Alzheimer's disease.

Galimberti D, Scarpini E.

Ther Adv Neurol Disord. 2011 Jul;4(4):203-16. doi: 10.1177/1756285611404470.

3.

[Therapy of Alzheimer disease].

Kovács T.

Neuropsychopharmacol Hung. 2009 Mar;11(1):27-33. Review. Hungarian.

4.

Treatment of Alzheimer's disease: symptomatic and disease-modifying approaches.

Galimberti D, Scarpini E.

Curr Aging Sci. 2010 Feb;3(1):46-56. Review.

PMID:
20298170
5.

Immunotherapy against amyloid pathology in Alzheimer's disease.

Galimberti D, Ghezzi L, Scarpini E.

J Neurol Sci. 2013 Oct 15;333(1-2):50-4. doi: 10.1016/j.jns.2012.12.013. Epub 2013 Jan 5. Review.

PMID:
23299047
6.

Current and future therapy in Alzheimer's disease.

van Marum RJ.

Fundam Clin Pharmacol. 2008 Jun;22(3):265-74. doi: 10.1111/j.1472-8206.2008.00578.x. Review.

PMID:
18485144
7.

Alzheimer's disease: from pathogenesis to disease-modifying approaches.

Galimberti D, Scarpini E.

CNS Neurol Disord Drug Targets. 2011 Mar;10(2):163-74. Review.

PMID:
21222635
8.

Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors.

Tayeb HO, Yang HD, Price BH, Tarazi FI.

Pharmacol Ther. 2012 Apr;134(1):8-25. doi: 10.1016/j.pharmthera.2011.12.002. Epub 2011 Dec 16. Review.

PMID:
22198801
10.

Disease modifying therapy for AD?

Golde TE.

J Neurochem. 2006 Nov;99(3):689-707. Review.

11.
13.

Progress in the development of new drugs in Alzheimer's disease.

Piau A, Nourhashémi F, Hein C, Caillaud C, Vellas B.

J Nutr Health Aging. 2011 Jan;15(1):45-57.

PMID:
21267520
14.

[Advanced dementia in Alzheimer's disease and memantine].

Alberca R.

Rev Neurol. 2005 Feb 1-15;40(3):173-9. Review. Spanish.

15.

The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.

Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP.

Postgrad Med. 2005 Jan;Spec No:6-22.

PMID:
17203561
16.

Current treatment for Alzheimer disease and future prospects.

Tariot PN, Federoff HJ.

Alzheimer Dis Assoc Disord. 2003 Jul-Sep;17 Suppl 4:S105-13. Review.

PMID:
14512816
17.

Anti-amyloid treatments in Alzheimer's disease.

Sapra M, Kim KY.

Recent Pat CNS Drug Discov. 2009 Jun;4(2):143-8. Review.

PMID:
19519562
18.
19.

Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.

Standridge JB.

Clin Ther. 2004 May;26(5):615-30. Review.

PMID:
15220008
20.

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.

O'Brien JT, Burns A; BAP Dementia Consensus Group.

J Psychopharmacol. 2011 Aug;25(8):997-1019. doi: 10.1177/0269881110387547. Epub 2010 Nov 18.

PMID:
21088041

Supplemental Content

Support Center